Target intelligence / Profile preview

Prokaryotic small ribosomal subunit (30S subunit) (30S subunit)

Target
30S subunit
Molecular classification
Other (ribosomal subunit; large macromolecular RNA-protein complex)
01

Overview

The **prokaryotic small ribosomal subunit** (30S subunit) is a large ribonucleoprotein complex unique to bacteria and archaea, composed of a single molecule of 16S rRNA and 21 ribosomal proteins. This subunit plays a central role in the translation of genetic information by providing the mRNA binding site, ensuring correct codon-anticodon pairing during decoding, and initiating protein synthesis in cooperation with translation factors and the 50S subunit. The 30S subunit is the molecular target for many clinically important antibiotics including aminoglycosides and tetracyclines, which act by interfering with decoding accuracy or translocation, ultimately inhibiting bacterial growth. The high degree of evolutionary conservation in its rRNA makes the subunit's 16S rRNA a gold standard for bacterial identification and phylogenetics. Because of its essential role in protein synthesis and its unique structure compared to eukaryotic cytoplasmic ribosomes, it is an important and validated antibacterial drug target, although risks of toxicity and resistance persist with 30S-targeting agents.

Other names
30S ribosomal subunitprokaryotic 30S ribosomal subunitbacterial 30S ribosomal subunitsmall ribosomal subunit (prokaryote)
02

Mechanism of action

Inhibition of translation by binding to functional sites on the 30S subunit (decoding or tRNA interaction regions); Misreading of genetic code (e.g., aminoglycosides like streptomycin induce errors during translation); Blockade of translocation and chain elongation (e.g., spectinomycin)

03

Biological functions

Translation of mRNA into proteinmRNA decoding (monitoring codon-anticodon pairing)Interaction with translation initiation factors (IF-1, IF-2, IF-3)Translocation of tRNA/mRNA during protein synthesisEvolutionary/phylogenetic marker (16S rRNA component)
04

Disease associations

Infection (major antibacterial drug target in pathogens)Other (phylogenetic marker for microbial classification)
05

Safety considerations

Human mitochondrial ribosomes are similar to prokaryotic ribosomes, so drugs targeting the 30S can cause off-target mitochondrial toxicity (e.g., nephrotoxicity, ototoxicity with aminoglycosides like streptomycin)Development of resistance (mutations in ribosomal proteins or 16S rRNA)
06

Interacting drugs

Streptomycin

5 more in the full profile.

07

Biomarkers

16S rRNA (used for phylogenetic identification, not typically for clinical patient selection)

Beyond the preview

Go deeper on Prokaryotic small ribosomal subunit (30S subunit) (30S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prokaryotic small ribosomal subunit (30S subunit) (30S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call